RHYTHM PHARMACEUTICALS
Rhythm is a biopharmaceutical company focused on developing and commercializing peptide therapeutics for the treatment of rare genetic deficiencies that result in life-threatening metabolic disorders. Their lead peptide product candidate, setmelanotide, is a potent, first-in-class melanocortin-4 receptor (MC4R) agonist for the treatment of rare genetic disorders of obesity. They believe that setmelanotide, for which they have exclusive worldwide rights, has the potential to serve as replacement therapy for the treatment of melanocortin 4, or MC4, pathway deficiencies. The MC4 pathway is a compelling target for treating these genetic disorders because of its critical role in regulating appetite and weight, and peptide therapeutics are uniquely suited to activating this target.
RHYTHM PHARMACEUTICALS
Industry:
Biotechnology Pharmaceutical Therapeutics
Founded:
2010-02-01
Address:
Boston, Massachusetts, United States
Country:
United States
Website Url:
http://www.rhythmtx.com
Total Employee:
101+
Status:
Active
Total Funding:
637.7 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
HealthCare Royalty Partners
HealthCare Royalty Partners investment in Post-IPO Debt - Rhythm Pharmaceuticals
Ipsen
Ipsen investment in Venture Round - Rhythm Pharmaceuticals
Third Rock Ventures
Third Rock Ventures investment in Venture Round - Rhythm Pharmaceuticals
New Enterprise Associates
New Enterprise Associates investment in Venture Round - Rhythm Pharmaceuticals
OrbiMed
OrbiMed investment in Venture Round - Rhythm Pharmaceuticals
Deerfield Capital Management
Deerfield Capital Management investment in Venture Round - Rhythm Pharmaceuticals
MPM Capital
MPM Capital investment in Venture Round - Rhythm Pharmaceuticals
Pfizer Venture Investments
Pfizer Venture Investments investment in Venture Round - Rhythm Pharmaceuticals
New Enterprise Associates
New Enterprise Associates investment in Series A - Rhythm Pharmaceuticals
MPM Capital
MPM Capital investment in Series A - Rhythm Pharmaceuticals
Key Employee Changes
Official Site Inspections
http://www.rhythmtx.com Semrush global rank: 1.77 M Semrush visits lastest month: 13.17 K
- Host name: 141.193.213.21
- IP address: 141.193.213.21
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Rhythm Pharmaceuticals"
Homepage - Rhythm Pharmaceuticals
Rhythm Pharmaceuticals is a global biopharmaceutical company committed to transforming the lives of patients with rare neuroendocrine diseases by rapidly advancing care and precision …See details»
Homepage | Rhythm Corporate
Our expertise and close collaboration with patients, caregivers, and healthcare professionals enable us to understand the complex challenges of rare MC4R pathway diseases and identify …See details»
Leadership - Rhythm Pharmaceuticals
Rhythm is guided by strong leadership at every level. We share an unrelenting drive to develop new therapies for rare neuroendocrine diseases, offering hope to patients and their families. …See details»
About - Rhythm Pharmaceuticals
Rhythm was founded in 2008 in Boston. Our lead asset, IMCIVREE® (setmelanotide), FDA-approved in 2020, is a precision medicine designed to treat severe obesity caused by an …See details»
Rhythm Pharmaceuticals Inc. - LinkedIn
Rhythm is a biopharmaceutical company aimed at developing and commercializing therapies for the treatment of rare MC4R pathway diseases.See details»
Homepage - Rhythm Pharmaceuticals HCP Site
We are committed to helping healthcare professionals understand, diagnose, and treat rare neuroendocrine diseases. A key neurosignaling pathway in the hypothalamus responsible for …See details»
Rhythm Pharmaceuticals - Crunchbase Company …
Rhythm is a biopharmaceutical company focused on developing and commercializing peptide therapeutics for the treatment of rare genetic deficiencies that result in life-threatening metabolic disorders. Their lead peptide product …See details»
Pioneering Hyperphagia Care for MC4R Pathway Diseases
We’re dedicated to transforming the lives of patients and their families living with hyperphagia and severe obesity caused by rare melanocortin-4 receptor (MC4R) pathway diseases by rapidly …See details»
Rhythm Pharmaceuticals is a biopharmaceutical company …
Rhythm Pharmaceuticals is advancing the clinical development program for setmelanotide, an MC4R agonist, as well as investigational MC4R agonists LB54640 and RM-718. In addition, …See details»
Release Details - Rhythm Pharmaceuticals, Inc.
BOSTON, July 23, 2024 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a commercial-stage biopharmaceutical company focused on transforming the lives of …See details»
Patients - Rhythm Pharmaceuticals
Rhythm is deeply committed not only to developing medicines for rare neuroendocrine diseases, but also to helping patients with these diseases receive the education, awareness, and access …See details»
Release Details - ir.rhythmtx.com
BOSTON, Dec. 11, 2020 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq:RYTM), a biopharmaceutical company aimed at developing and commercializing …See details»
Rhythm Pharmaceuticals Inc. Information - RocketReach
Rhythm Pharmaceuticals Inc. is a Biotechnology Research, Pharmaceuticals, and Healthcare company located in Boston, Massachusetts with $66.2 million in revenue and 272 employees. …See details»
Rhythm Pharmaceuticals appoints Board Chairman Dr David
Jul 20, 2020 · Rhythm is a late-stage biopharmaceutical company focused on the development and commercialization of therapies for the treatment of rare genetic disorders of obesity.See details»
Rhythm Pharmaceuticals Announces Participation in Upcoming …
BOSTON, Nov. 06, 2024 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused on transforming the …See details»
Rhythm Pharmaceuticals, Inc. (RYTM) - Yahoo Finance
Find the latest Rhythm Pharmaceuticals, Inc. (RYTM) stock quote, history, news and other vital information to help you with your stock trading and investing.See details»
Science - Rhythm Pharmaceuticals
At Rhythm, we are dedicated to discovering therapies for rare neuroendocrine diseases. Our science is focused on developing therapies for patients with hyperphagia (insatiable hunger) …See details»
Overview, News & Similar companies - ZoomInfo.com
Jun 11, 2024 · Rhythm Pharmaceuticals contact info: Phone number: (857) 264-4280 Website: www.rhythmtx.com What does Rhythm Pharmaceuticals do? Were dedicated to transforming …See details»
Careers - Rhythm Pharmaceuticals
At Rhythm, we know our work makes an important difference in the lives of patients and their families around the world. Every employee contributes to the company’s goal of discovering …See details»
RYTM Stock Price Quote | Morningstar
Nov 8, 2024 · See the latest Rhythm Pharmaceuticals Inc stock price (RYTM:XNAS), related news, valuation, dividends and more to help you make your investing decisions.See details»